Research Site

Lisle, Illinois 60532

We've found

1 trials

at this facility

Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Lisle, IL

Use our guide to learn which trials are right for you!